JPH043983B2 - - Google Patents
Info
- Publication number
- JPH043983B2 JPH043983B2 JP57056293A JP5629382A JPH043983B2 JP H043983 B2 JPH043983 B2 JP H043983B2 JP 57056293 A JP57056293 A JP 57056293A JP 5629382 A JP5629382 A JP 5629382A JP H043983 B2 JPH043983 B2 JP H043983B2
- Authority
- JP
- Japan
- Prior art keywords
- header
- coating film
- blood
- graft
- thermoplastic polymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000008280 blood Substances 0.000 claims description 36
- 239000011248 coating agent Substances 0.000 claims description 36
- 210000004369 blood Anatomy 0.000 claims description 35
- 238000000576 coating method Methods 0.000 claims description 35
- 238000000034 method Methods 0.000 claims description 27
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical group OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 19
- 229960002897 heparin Drugs 0.000 claims description 19
- 229920000669 heparin Polymers 0.000 claims description 19
- 238000012545 processing Methods 0.000 claims description 11
- VOZRXNHHFUQHIL-UHFFFAOYSA-N glycidyl methacrylate Chemical compound CC(=C)C(=O)OCC1CO1 VOZRXNHHFUQHIL-UHFFFAOYSA-N 0.000 claims description 8
- 229920001169 thermoplastic Polymers 0.000 claims description 7
- 238000010438 heat treatment Methods 0.000 claims description 6
- 239000000178 monomer Substances 0.000 claims description 5
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 claims description 4
- 229920000642 polymer Polymers 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical group NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims description 2
- 239000001856 Ethyl cellulose Substances 0.000 claims description 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical group CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims description 2
- 125000003700 epoxy group Chemical group 0.000 claims description 2
- 229920001249 ethyl cellulose Polymers 0.000 claims description 2
- 235000019325 ethyl cellulose Nutrition 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 3
- 150000001875 compounds Chemical class 0.000 claims 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims 1
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 claims 1
- 229920002301 cellulose acetate Polymers 0.000 claims 1
- 238000007334 copolymerization reaction Methods 0.000 claims 1
- 239000005038 ethylene vinyl acetate Substances 0.000 claims 1
- 230000009477 glass transition Effects 0.000 claims 1
- 238000010559 graft polymerization reaction Methods 0.000 claims 1
- 230000000379 polymerizing effect Effects 0.000 claims 1
- 229920003048 styrene butadiene rubber Polymers 0.000 claims 1
- 210000003734 kidney Anatomy 0.000 description 15
- 239000000243 solution Substances 0.000 description 13
- 238000012360 testing method Methods 0.000 description 13
- 239000000463 material Substances 0.000 description 12
- 239000012528 membrane Substances 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- 239000007921 spray Substances 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical class CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 230000004087 circulation Effects 0.000 description 4
- 239000012510 hollow fiber Substances 0.000 description 4
- 229920005668 polycarbonate resin Polymers 0.000 description 4
- 239000004431 polycarbonate resin Substances 0.000 description 4
- 241000282472 Canis lupus familiaris Species 0.000 description 3
- 239000004743 Polypropylene Substances 0.000 description 3
- 230000002429 anti-coagulating effect Effects 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 230000023555 blood coagulation Effects 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- -1 polypropylene Polymers 0.000 description 3
- 229920001155 polypropylene Polymers 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- XMPZTFVPEKAKFH-UHFFFAOYSA-P ceric ammonium nitrate Chemical compound [NH4+].[NH4+].[Ce+4].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O XMPZTFVPEKAKFH-UHFFFAOYSA-P 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000001112 coagulating effect Effects 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 239000000306 component Substances 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 210000004731 jugular vein Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 235000011121 sodium hydroxide Nutrition 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- JTXMVXSTHSMVQF-UHFFFAOYSA-N 2-acetyloxyethyl acetate Chemical compound CC(=O)OCCOC(C)=O JTXMVXSTHSMVQF-UHFFFAOYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 208000005156 Dehydration Diseases 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- 229920001893 acrylonitrile styrene Polymers 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- 210000001715 carotid artery Anatomy 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 229920006026 co-polymeric resin Polymers 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 238000001631 haemodialysis Methods 0.000 description 1
- 230000000322 hemodialysis Effects 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- SCUZVMOVTVSBLE-UHFFFAOYSA-N prop-2-enenitrile;styrene Chemical compound C=CC#N.C=CC1=CC=CC=C1 SCUZVMOVTVSBLE-UHFFFAOYSA-N 0.000 description 1
- 239000002510 pyrogen Substances 0.000 description 1
- 239000002964 rayon Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate group Chemical group S(=O)(=O)([O-])[O-] QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 238000009834 vaporization Methods 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- External Artificial Organs (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5629382A JPS58173557A (ja) | 1982-04-05 | 1982-04-05 | 血液処理装置用ヘツダ−およびその製法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5629382A JPS58173557A (ja) | 1982-04-05 | 1982-04-05 | 血液処理装置用ヘツダ−およびその製法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS58173557A JPS58173557A (ja) | 1983-10-12 |
| JPH043983B2 true JPH043983B2 (fr) | 1992-01-24 |
Family
ID=13023055
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP5629382A Granted JPS58173557A (ja) | 1982-04-05 | 1982-04-05 | 血液処理装置用ヘツダ−およびその製法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS58173557A (fr) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5236779A (en) * | 1975-09-18 | 1977-03-22 | Showa Electric Wire & Cable Co Ltd | Electromagnetic shielding cable |
| JPS53137268A (en) * | 1977-05-06 | 1978-11-30 | Agency Of Ind Science & Technol | Preparation of anticoagulative polyurethane |
| JPS5483095A (en) * | 1977-12-15 | 1979-07-02 | Unitika Ltd | Preparation of anti-thrombogenetic polyamide |
-
1982
- 1982-04-05 JP JP5629382A patent/JPS58173557A/ja active Granted
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5236779A (en) * | 1975-09-18 | 1977-03-22 | Showa Electric Wire & Cable Co Ltd | Electromagnetic shielding cable |
| JPS53137268A (en) * | 1977-05-06 | 1978-11-30 | Agency Of Ind Science & Technol | Preparation of anticoagulative polyurethane |
| JPS5483095A (en) * | 1977-12-15 | 1979-07-02 | Unitika Ltd | Preparation of anti-thrombogenetic polyamide |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS58173557A (ja) | 1983-10-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5165919A (en) | Medical material containing covalently bound heparin and process for its production | |
| EP0267286B1 (fr) | Filtre pour l'extraction selective de leucocytes | |
| DE69018691T2 (de) | Medizinische Anordnung mit hochbiokompatibler Oberfläche und Verfahren zu deren Herstellung. | |
| US5028332A (en) | Hydrophilic material and method of manufacturing | |
| WO1993015775A1 (fr) | Procede de production d'une matiere antithrombogene, et matiere produite par ce procede | |
| DE69013457T2 (de) | Antithrombotisches blutbehandlungssystem. | |
| DE2326863A1 (de) | Verfahren zur herstellung biokompatibler und biofunktioneller materialien | |
| JPH04152952A (ja) | 生体適合性医用材料 | |
| WO1999001195A1 (fr) | Elimination d'agents biologiquement actifs | |
| DE69218477T2 (de) | Medizinisches Material, Verfahren zu seiner Herstellung und medizinisches Gerät | |
| JPH07184989A (ja) | 血液適合性医療用高分子材料および医療材料 | |
| JP3640737B2 (ja) | ポリスルホン系選択透過性中空糸膜 | |
| WO1993016117A1 (fr) | Derive de cellulose hydrosoluble et materiau biocompatible | |
| JPH043983B2 (fr) | ||
| JP3495802B2 (ja) | 医療用材料およびホスホリルコリン基を有するポリビニルアルコール系重合体 | |
| JP6992111B2 (ja) | 血液処理用分離膜及びその膜を組み込んだ血液処理器 | |
| EP0484057A2 (fr) | Surfaces antithrombogènes, leur préparation et matériau pour leur préparation | |
| JPS6316969B2 (fr) | ||
| EP0534014A1 (fr) | Surface biocompatible non-adhérente | |
| Kamath et al. | Albumin grafting on dimethyldichlorosilane-coated glass by gamma-irradiation | |
| JPS6320552B2 (fr) | ||
| US5180789A (en) | Medical materials and process for preparing the same | |
| JPH07284528A (ja) | 医療材料用合成高分子 | |
| KR100229579B1 (ko) | 개질 키토산으로 도포된 백혈구 제거용 필터 | |
| JP2926984B2 (ja) | 抗血栓性血液処理システム |